ITEM VIEW

11-ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer : potent androgens which can no longer be ignored

dc.contributor.authorPretorius, Elzetteen_ZA
dc.contributor.authorAfricander, Donita J.en_ZA
dc.contributor.authorVlok, Mareen_ZA
dc.contributor.authorPerkins, Meghan S.en_ZA
dc.contributor.authorQuanson, Jonathanen_ZA
dc.contributor.authorStorbeck, Karl-Heinzen_ZA
dc.date.accessioned2016-07-22T12:19:03Z
dc.date.available2016-07-22T12:19:03Z
dc.date.issued2016
dc.identifier.citationPretorius, E., et al. 2016. 11-ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer : potent androgens which can no longer be ignored. PLoS ONE, 11(7):1-17, doi:10.1371/journal.pone.0159867
dc.identifier.issn1932-6203 (online)
dc.identifier.otherdoi:10.1371/journal.pone.0159867
dc.identifier.urihttp://hdl.handle.net/10019.1/99223
dc.descriptionCITATION: Pretorius, E., et al. 2016. 11-ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer : potent androgens which can no longer be ignored. PLoS ONE, 11(7):1-17, doi:10.1371/journal.pone.0159867.
dc.descriptionThe original publication is available at http://journals.plos.org/plosone
dc.descriptionPublication of this article was funded by the Stellenbosch University Open Access Fund.
dc.description.abstractDihydrotestosterone (DHT) is regarded as the most potent natural androgen and is implicated in the development and progression of castration resistant prostate cancer (CRPC). Under castrate conditions, DHT is produced from the metabolism of the adrenal androgen precursors, DHEA and androstenedione. Recent studies have shown that the adrenal steroid 11β-hydroxyandrostenedione (11OHA4) serves as the precursor to the androgens 11-ketotestosterone (11KT) and 11-ketodihydrotestosterone (11KDHT). In this study we comprehensively assess the androgenic activity of 11KT and 11KDHT. This is the first study, to our knowledge, to show that 11KT and 11KDHT, like T and DHT, are potent and efficacious agonists of the human androgen receptor (AR) and induced both the expression of representative AR-regulated genes as well as cellular proliferation in the androgen dependent prostate cancer cell lines, LNCaP and VCaP. Proteomic analysis revealed that 11KDHT regulated the expression of more AR-regulated proteins than DHT in VCaP cells, while in vitro conversion assays showed that 11KT and 11KDHT are metabolized at a significantly lower rate in both LNCaP and VCaP cells when compared to T and DHT, respectively. Our findings show that 11KT and 11KDHT are bona fide androgens capable of inducing androgen-dependant gene expression and cell growth, and that these steroids have the potential to remain active longer than T and DHT due to the decreased rate at which they are metabolised. Collectively, our data demonstrates that 11KT and 11KDHT likely play a vital, but overlooked, role in the development and progression of CRPC.en_ZA
dc.format.extent17 pages
dc.language.isoen_ZAen_ZA
dc.publisherPublic Library of Science
dc.subjectProstate canceren_ZA
dc.subjectAndrogensen_ZA
dc.title11-ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer : potent androgens which can no longer be ignoreden_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's version
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW